TTM Technologies delivered its strongest quarter on record and paired it with a preliminary 2027 forecast that changes the scale of the story. Non-GAAP EPS of $1.46 beat the $1.25 consensus by 14.1% and topped the $1.28 Earnings Whisper number. Earnings grew 124.6% year over year. Revenue of $1.204 billion beat the $1.13 billion consensus by 6.5% and rose 59.9%. That extends a clear acceleration in top-line growth, from 30% in Q1 to 37% in Q2 to 60% now. Management then guided Q4 revenue to $1.42-$1.44 billion and introduced 2027 targets of $6.5-$6.75 billion in sales and $8.10-$8.90 in non-GAAP EPS. That revenue range implies roughly 50% growth and replaces the 15-20% organic framework the company reiterated just one quarter ago. The central tension is that this blowout arrived alongside a miss in the very segment investors care about most, and alongside a sharp pivot toward debt-funded M&A.

The operating improvement is genuine. Gross margin expanded to 24.2% on a GAAP basis from 20.8% a year ago. Adjusted EBITDA margin cleared 20% for the first time at 20.1%, up from 16.6% in Q2. Commercial segment operating income nearly tripled to $166.3 million. The quality of the beat still deserves some scrutiny below the operating line. GAAP EPS was $0.79, little more than half the non-GAAP figure, for three reasons:

• The tax provision jumped to $56.9 million on $141.7 million of pretax income.
• Stock-based compensation roughly doubled to $24.1 million.
• The company booked $13.6 million of acquisition-related charges and $6.1 million of derivative losses.

Cash generation held up better than those GAAP figures suggest. Operating cash flow was $154.7 million and free cash flow was $74.8 million, continuing a steady climb from negative $85 million in Q1.

Demand indicators were the call's standout. Book-to-bill surged to 2.13, with commercial at roughly 2.5, after readings of 1.41 and 1.49 in the prior two quarters. The 90-day backlog jumped 111% year over year to $1.3 billion. Aerospace & Defense growth accelerated for a third straight quarter, reaching 21%, and program backlog hit a record $2.0 billion. Management raised its full-year A&D growth outlook to about 20%, lifted MI&I to nearly 70% from 35-40%, and flipped automotive from a decline to growth. Data Center & Networking was the exception. It was up 115% year over year, but it ran roughly 10% below management's Q3 plan, at 41% of sales versus the 49% guided in Q2, because one of three M+M programs slipped on customer scheduling. M+M revenue barely cleared the $200 million plan in Q3, and Q4 is now expected slightly below the prior ~$400 million target.

The forward story now leans heavily on that same M+M ramp and on acquisitions. Management expects M+M to grow from about 30% to about 50% of data center revenue in 2027 across 5-10 programs. To support that, it committed another $400 million of capacity spending. Meanwhile, the company that framed growth as purely organic in February has closed STG and Epiq, is finishing ILFA, and has announced the Merlin PCB deals. It also agreed to buy Ophir Optics for $650 million in cash, or about 10x 2027 EBITDA. Bears have legitimate ammunition here:

• Q4 interest expense is expected to roughly triple to about $34 million.
• Net leverage stood at 2.8x pro forma after the Epiq close, versus 0.9x in Q2. Management expects to return to its 1.5-2.0x target by the time Ophir closes.
• Integration risk now spans five-plus deals.
• Lead times for key materials are stretching to 12-24+ weeks.
• Data center revenue is concentrated in a handful of AI customers.

The market was not giving TTM the benefit of the doubt going into the print. Shares closed at $102.15 the day before the report. That was 22.5% below the opening price after the August release and 20% below the 200-day moving average. The stock had surrendered its entire post-report spike to $149.94 and traded within about 11% of its October 15 low of $92.15. Investor sentiment remained positive but weakened meaningfully, falling from 0.40 to 0.16. The trend readings are split along the same line. Sequential growth and momentum remain positive, while price and AVWAP trends are negative, reflecting improving fundamentals against weak stock behavior.

The bottom line is that TTM delivered accelerating growth, record margins, surging bookings and a 2027 outlook far above anything the market had framed. The DC&N shortfall reads as a timing slip rather than lost demand. Still, it lands on the M+M ramp that underpins the 2027 targets, at the same moment the balance sheet is absorbing a debt-funded acquisition spree. With the stock deeply oversold relative to its fundamentals, execution on program timing and integration will determine whether the market closes that gap.